INOCOR
LOE ApproachingNDAINJECTIONINJECTABLE
Approved
Jul 1984
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
2
Data completeness
2/8 — Basic
Drug data last refreshed 16h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
INOCOR is a small-molecule injectable product approved in 1984 for inotropic support in acute decompensated heart failure and cardiogenic shock. The drug's exact mechanism of action and pharmacologic class are not publicly detailed in available sources, but it functions as an inotropic agent to improve cardiac contractility. It is administered via injection for acute clinical settings.
LOE Approaching
As LOE approaches, the brand team is likely focused on retention and lifecycle management rather than growth, with modest headcount expectations.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (2)
Assess the Efficacy and Safety of Rhinocort Aqua
Started Apr 2004
650 enrolled
Allergic Rhinitis
Rhinocort Aqua Versus Placebo and Fluticasone Propionate
Started Apr 2003
750 enrolled
Seasonal Allergic Rhinitis
Career Relevance
INOCOR currently shows zero linked job openings, reflecting its mature, niche status and approaching LOE. Career opportunities are limited and primarily focused on defending market share in acute-care settings rather than expansion.
Brand Manager
Worked on INOCOR at Sanofi? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.